High materiality8/10
Moderna price target raised to $137 from $120 at Goldman Sachs
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: Goldman Sachs raises MRNA target to $137; current price $226.3.
- Target: $137; Posted price: $226.3; Firm: Goldman Sachs
Key facts
- 01
Target: $137
- 02
Posted price: $226.3
- 03
Analyst firm: Goldman Sachs
- 04
Analyst: Salveen Richter
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.